Friday, June 10, 2022

News From #ASCO22 Part 3, Addressing Challenges in Ovarian Cancer

Repeating PARP maintenance in ovarian cancer recurrence may have only a small benefit.

 

 

HIPEC  

 
 6/5
Challenges in OC #ASCO22 #gyncsm
Van Driel - HIPEC: Is It Ready for Prime Time in Ovarian Cancer?
Multidisciplinary team and surgical skills needed to use HIPEC.

Use Hipec in combo with Cytoreductive surgery. pic.twitter.com/CbBoHthWvP

 

Check back on Monday for my take on the Gyn Cancer Poster Discussion session.

Dee
Every Day is a Blessing!

No comments: